Atlas Trials

Safety and Immune Response of COVID-19 Vaccination in Patients With Chronic Liver Diseases

Clinical trial NCT05007665 · UNKNOWN

Trial details

NCT number
NCT05007665
Sponsor
The Second Affiliated Hospital of Chongqing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Liver DiseasesCovid19Adverse Reaction to Vaccine
Start date
2021-07-01
Primary completion
2023-06-30
Enrollment
2000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.